Contact

Careers
Country websites

Investors

Conference Call on Q4 and full year 2025 financial results

The Conference Call on Q4 and full year 2025 took place on February 24, 2026 

Learn more
Investor Presentation

Investor Presentation

Our current presentation for investors including strategy, financial data and outlook

Learn more
204040-GlenBurnie, Glen Burnie, Maryland - November 22: Fresenius Kidney Care on November 22, 2024 (Photo by Ferran Traite Soler/Getty Images for Fresenius Medical Care

Sustainability

Managing sustainability successfully means creating lasting value – economically, ecologically and socially.

Learn more
Contacts

Contacts

The Investor Relations Team is pleased to answer your questions regarding our share, financial performance or other capital market related questions.

Learn more
Meeting_room

Q4 and full year 2025 financial results

Investor Presentation

Investor Presentation

Sustainability

Sustainability

Contact

Contact

Helen Giza
Fresenius Medical Care closed a milestone year marked by outstanding profitability gains. Over the past three years, we built a stronger and more resilient company, meeting all key financial and strategic aspects of the mid-term outlook that we had set for 2025. These achievements reflect our disciplined focus on operational and financial excellence. In 2025, we delivered revenue and operating income growth at the upper end of our outlook, overcoming a difficult market environment,
Looking ahead to 2026, we are set to build on the remarkable transformation of recent years and advance the execution of our FME Reignite strategy. For our patients, we are excited to expand access to high-volume hemodiafiltration in the U.S. with the large-scale rollout of our innovative 5008X CAREsystem. We remain steadfast in our commitment to further improve profitability, while investing in our future and overcoming regulatory headwinds. As such, we expect to grow operating income by three to seven percent CAGR out to 2028 and to increase returns for our shareholders..

Helen Giza

Chief Executive Officer

Latest Documents

pdf

Investor Presentation

PDF, 6 MB
Links

Replay 
Transcript

Analyst Presentation

PDF

Financial Calendar

List View

Grid View

04/21/2026 - 05/04/2026 | Reporting

Q1 2026 Quiet Period

Save the date

05/05/2026 | Reporting

Report on 1st quarter 2026: Earnings Release and Conference Call

Save the date

05/08/2026 | Reporting

Q1 financial report

Save the date

05/21/2026 | General Meeting

Annual General Meeting 2026

Save the date

Event Calendar

List View

Grid View

03/05/2026 | Roadshow

C-Level Roadshow

Boston

Save the date

03/10/2026 - 03/11/2026 | Conference

Barclays Global Healthcare Conference

Miami

Save the date

03/19/2026 | Conference

Bernstein ESG Conference

Paris

Save the date

03/24/2026 | Conference

BNPP Exane Healthcare Conference

Paris

Save the date

You are interested in our news?

Order our news

Would you like to be included on our distribution list for our news? We would be happy to provide you with our latest press releases and short news by e-mail. This service is free of charge and may be cancelled at any time.

You can cancel this free service at any time by sending an e-mail to
ir(at)freseniusmedicalcare.com, or by calling +49 (0) 6172 609 2525.

The information you provide will only be used to answer your query. For more information on how we process your Personal Data please read our 
privacy policy.

Media center
See all stories
No Results Found
See all stories
PREVIOUS
    NEXT
    Events
    See all events
    No Results Found
    See all events
    PREVIOUS
      NEXT
      Contact
      Country websites

      All contact information

      Social Media

      © Fresenius Medical Care AG 2026

      Privacy policy

      Cookie settings

      Imprint